Opening book details…
About this Medicine article
O-010 An international phase III randomized, non-inferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy for colon cancer: compliance and safety of the phase III Japanese ACHIEVE trial by Eto, T.; Kotaka, M.; Manaka, D.; Hasegawa, J.; Takagane, A.; Nakamura, M.; Kato, T.; Munemoto, Y.; Nakamura, F.; Bando, H.; Taniguchi, H.; Gamoh, M.; Shiozawa, M.; Yamanaka, T.; Mizushima, T.; Sakamoto, J.; Saji, S.; Mori, M.; Ohtsu, A.; Yoshino, T. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Eto, T.; Kotaka, M.; Manaka, D.; Hasegawa, J.; Takagane, A.; Nakamura, M.; Kato, T.; Munemoto, Y.; Nakamura, F.; Bando, H.; Taniguchi, H.; Gamoh, M.; Shiozawa, M.; Yamanaka, T.; Mizushima, T.; Sakamoto, J.; Saji, S.; Mori, M.; Ohtsu, A.; Yoshino, T.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2016
- Field
- Medicine (Health Sciences)